BASSI P F ET AL: "Paclitaxel-Hyaluronic Acid for Intravesical Therapy of Bacillus Calmette-Guerin Refractory Carcinoma In Situ of the Bladder: Results of a Phase I Study", JOURNAL OF UROLOGY, LIPPINCOTT WILLIAMS & WILKINS, BALTIMORE, MD, US, vol. 185, no. 2, 1 February 2011 (2011-02-01), pages 445-449, XP027595068, ISSN: 0022-5347, DOI: 10.1016/J.JURO.2010.09.073 [retrieved on 2011-01-09] (B1)

BASSI P.F. ET AL: "Oncofid-P-B (paclitaxel-hyaluronic acid) in the intravesical therapy of patiens affected by primary or recurrent Ta G1-G2 papillary cancer of the bladder. A hpase II marker lesion study.", EUR UROL SUPPL 2018, 33RD ANNUAL EAU CONGRESS COPENHAGEN, vol. 17, no. 2, 1 February 2011 (2011-02-01), page e1056, (B1)

WO-A2-2004/035629 (B1)

MONICA CAMPISI ET AL: "ONCOFID(TM)-P a Hyaluronic Acid Paclitaxel Conjugate for the Treatment of Refractory Bladder Cancer and Peritoneal Carcinosis", CURRENT BIOACTIVE COMPOUNDS, vol. 7, no. 1, 1 March 2011 (2011-03-01), pages 27-32, XP055599334, ISSN: 1573-4072, DOI: 10.2174/157340711795163848 (B1)

ROSATO A ET AL: "HYTAD1-p20: A new paclitaxel-hyaluronic acid hydrosoluble bioconjugate for treatment of superficial bladder cancer", UROLOGIC ONCOLOGY: SEMINARS AND ORIGINAL INVESTIGATIONS, ELSEVIER, AMSTERDAM, NL, vol. 24, no. 3, 1 May 2006 (2006-05-01), pages 207-215, XP028071920, ISSN: 1078-1439, DOI: 10.1016/J.UROLONC.2005.08.020 [retrieved on 2006-05-01] (B1)

ISABELLA MONIA MONTAGNER ET AL: "Paclitaxel-hyaluronan hydrosoluble bioconjugate: Mechanism of action in human bladder cancer cell lines", UROLOGIC ONCOLOGY: SEMINARS AND ORIGINAL INVESTIGATIONS, vol. 31, no. 7, 1 October 2013 (2013-10-01), pages 1261-1269, XP055414808, AMSTERDAM, NL ISSN: 1078-1439, DOI: 10.1016/j.urolonc.2012.01.005 (B1)